Waste Management (WM): What This Company Actually Does

How WM makes money

WM collects trash from homes and businesses using its own truck fleet, moves it through transfer stations, and disposes of most of it in landfills — and increasingly incinerators and recycling facilities — that it owns and operates outright. Because it earns money at multiple points in that chain (collection fee, disposal fee, and a byproduct sale of the methane landfills naturally produce, converted to electricity or renewable natural gas), WM effectively gets paid three times on the same load of trash.

Collection and disposal fees made up $23.7B of FY2025's $25.2B net revenue; byproduct sales added another $2.0B. Source: 10-K FY2025, p.4 (business structure, five reportable segments).

Where the revenue comes from

Collection & Landfill makes up 82% of revenue and effectively all of consolidated operating income. Healthcare Solutions — formerly Stericycle, acquired in November 2024 — has already grown to 10% of revenue but is still running an operating loss as integration continues.

Source: 10-K FY2025, p.47 (revenue composition), p.129 (Note 19, segment financial information).

Customers and competitors

Customers span municipal governments (collection contracts), commercial facilities, industrial operations, and households — a mixed B2G/B2B/B2C base. In FY2025, the largest single customer accounted for less than 5% of total revenue, so customer concentration risk is low.

• Republic Services (RSG) — the #2 player and closest direct competitor, with the most similar business model and regional strategy.
• Waste Connections (WCN) — #3, focused on smaller markets with less competition, pursuing wider margins.
• GFL Environmental (GFL) — a Canada-based challenger growing quickly through debt-funded M&A.

Source: 10-K FY2025, p.4 (customer concentration); web search, competitor positioning (accessed Aug 23, 2026).

The metric that matters most in this sector

"Yield" — the price increase WM pushes through on its Collection & Landfill business — shows whether the company has pricing power even without volume growth. Because new landfill permits are extremely difficult to obtain, landfills are a scarce asset, and that scarcity typically gives operators like WM pricing power that lasts longer than in most industries.

Yield has decelerated every year since 2022, from 6.7% to 3.8% — consistent with broader inflation cooling, which has reduced how much pricing power WM needs to exercise, though the underlying scarcity-driven pricing power hasn't disappeared.

Source: 10-K FY2025, p.48; 10-K FY2024, p.49; 10-K FY2023, p.44 (annual Collection & Landfill yield tables).

Leadership and ownership

CEO James C. (Jim) Fish, Jr. has led WM since 2016 (about 10 years), an internal promotion who previously served as CFO — not a founder (the company traces to a 1987 founding and a 1998 merger that produced its current name), and no founder remains active in management. In May 2025, John Morris was promoted to President and COO, strengthening the succession bench. The largest shareholders are Vanguard (9.0%), the Gates Foundation Trust (7.2%) — a notable holder for a #3 shareholder position — and BlackRock (7.1%).

Source: DEF 14A 2026, p.21 (CEO bio), p.29 (5%+ shareholders).

Capital returns

WM raised its 2026 quarterly dividend from $0.825 to $0.945 (+14.5%) — its 23rd consecutive annual increase — yielding about 1.7% at the current price. Share buybacks, however, stopped entirely in 2025 while the company paid down debt from the Stericycle acquisition. A new $3 billion buyback authorization was approved in December 2025, with repurchases resuming in February 2026 and roughly $2 billion expected for the year.

Source: 10-K FY2025, p.4 (dividend and buyback announcements), p.41 (Item 5, share repurchase activity).

How this company could fail

• Stericycle integration aftermath — the $7.2B Healthcare Solutions segment (formerly Stericycle) still posted an operating loss (-$88M) in 2025, and net debt-to-EBITDA jumped from 2.79x (2023) to 3.71x (2024) to fund the deal. Interest expense rose 82% from $500M (2023) to $912M (2025), and 2025 net income actually fell slightly (-1.4%) as a result.
• Commodity price volatility in recycling and renewable energy — average recycled-commodity market prices (single-stream basis) fell about 20% year over year in 2025, and renewable-energy revenue depends on government-linked credit prices (RINs, RECs) — leaving roughly 8% of revenue exposed to factors outside the company's control.
• Landfill environmental liabilities and regulation — final capping, closure, and post-closure reserves are large enough that auditors flag them as a Critical Audit Matter requiring significant estimation judgment, even as new landfill capacity keeps getting harder to permit.

Source: 10-K FY2025, p.23–37 (Item 1A Risk Factors), p.127 (auditor's report, Critical Audit Matters).

Five-year financials

Source: 10-K FY2025 p.48 (highlights), p.64 (FCF reconciliation), p.78 (income statement), p.79 (cash flow statement); 10-K FY2023 p.63, 76; 10-K FY2022 p.56 (2021-2022 figures). EBITDA figures are estimated as operating income plus depreciation and amortization (a non-GAAP proxy, not company-reported).

What we still don't know

• Exactly when Healthcare Solutions turns profitable isn't determinable from this data alone — it requires checking results after the Q2 2026 earnings release (Jul 29, 2026).
• Whether the full $2B buyback target for 2026 will actually be completed, and what specific leverage target (net debt/EBITDA) management is aiming for aren't specified in the 10-K.
• Total remaining permitted landfill airspace company-wide is disclosed only landfill-by-landfill in Item 2 Properties, making it impossible to quantify a single company-wide "years of capacity remaining" figure from this card alone.